D
Amylyx Pharmaceuticals, Inc. AMLX
$3.63 -$0.045-1.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 87.37M 196.49M 298.76M 398.00M 380.79M
Total Other Revenue -- -- -- -- --
Total Revenue 87.37M 196.49M 298.76M 398.00M 380.79M
Cost of Revenue 228.72M 296.30M 273.31M 277.17M 153.63M
Gross Profit -141.35M -99.82M 25.45M 120.83M 227.16M
SG&A Expenses 114.33M 149.48M 180.37M 202.11M 188.36M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 22.85M 22.85M 22.85M -- --
Total Operating Expenses 402.10M 468.63M 476.52M 479.28M 341.98M
Operating Income -314.73M -272.14M -177.76M -81.28M 38.80M
Income Before Tax -302.14M -257.48M -162.36M -65.66M 54.30M
Income Tax Expenses -393.00K 1.99M 3.51M 5.44M 5.03M
Earnings from Continuing Operations -301.74 -259.47 -165.87 -71.10 49.27
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -301.74M -259.47M -165.87M -71.10M 49.27M
EBIT -314.73M -272.14M -177.76M -81.28M 38.80M
EBITDA -313.83M -271.10M -176.64M -80.08M 39.89M
EPS Basic -4.43 -3.82 -2.44 -1.04 0.73
Normalized Basic EPS -2.87 -2.46 -1.58 -0.69 0.41
EPS Diluted -4.44 -3.82 -2.45 -1.07 0.70
Normalized Diluted EPS -2.87 -2.46 -1.59 -0.71 0.40
Average Basic Shares Outstanding 272.56M 271.39M 270.71M 269.92M 268.78M
Average Diluted Shares Outstanding 272.56M 273.17M 274.82M 276.93M 279.94M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings